0001127602-22-013535.txt : 20220507
0001127602-22-013535.hdr.sgml : 20220506
20220505171923
ACCESSION NUMBER: 0001127602-22-013535
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220503
FILED AS OF DATE: 20220505
DATE AS OF CHANGE: 20220505
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karachun Rita A
CENTRAL INDEX KEY: 0001601572
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 22897744
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-05-03
0000310158
Merck & Co., Inc.
MRK
0001601572
Karachun Rita A
MERCK & CO., INC.
2000 GALLOPING HILL ROAD
KENILWORTH
NJ
07033
1
Sr. VP Fince-Global Controller
Common Stock
2022-05-04
4
M
0
949
87.10
A
41428.972
D
Common Stock
2022-05-04
4
F
0
326
87.10
D
41102.972
D
Stock Option (Right to Buy)
87.10
2022-05-03
4
A
0
13592
0
A
2023-05-03
2032-05-02
Common Stock
13592
13592
D
Restricted Stock Unit
2022-05-03
4
A
0
2411
0
A
2023-05-03
2025-05-03
Common Stock
2411
2411
D
Restricted Stock Unit
2022-05-04
4
M
0
949
0
D
2022-05-04
2024-05-04
Common Stock
949
1900
D
Holdings include shares acquired in dividend reinvestment transactions.
The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.
Holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. ("Organon") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the "Form 10"). As reported in the Form 10, all Merck restricted stock unit awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments.
These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
/s/ Kelly E. W. Grez as Attorney-in-Fact for Rita Karachun
2022-05-05